Orthofix Medical Inc.

OFIX

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001193125-26-094459
Filing date: Mar 5, 2026
Earliest execution date: Mar 3, 2026
Reporting Owners: Fisher Patrick (President)

Summary

Type

Neutral

Net shares

+21,105

% of shares

67.94%

Amount (USD)

$0

Insider confidence score

90.0 out of 100

Positive

  • Massive buy (≥10% of shares)

Negative

  • Minimal buy amount (<$10K)

Stock transactions

Transaction 1

Security

Common Stock

Action

Grant

Date

2026-03-03

Code

A

Net shares

+21,105.0

Acquired/Disposed

Acquired

Shares Owned Before

31,064.0

Shares Owned After

52,169.0

Derivative Transactions

Transaction 1

Security

Employee Stock Option (Right to Buy)

Action

Grant

Date

2026-03-03

Code

A

Net shares

+50,101.0

Acquired/Disposed

Acquired

Shares Owned Before

0.0

Shares Owned After

50,101.0

Filing's footnotes

1. Represents a grant of restricted stock units approved by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered thereby on the first, second and third anniversary of the Grant Date.

2. Includes 24,936 previously reported restricted stock units and 948 shares acquired under Orthofix's Stock Purchase Plan (&quot;Orthofix's SPP&quot;) on 10/31/2025. Orthofix's SPP is a &quot;Stock Purchase Plan&quot; as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b).

3. The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first, second and third anniversary of the Grant Date.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.